10:28 AM EST, 12/27/2024 (MT Newswires) -- Nutriband ( NTRB ) said Friday it has completed the registration process to extend its Chinese patent to Macao for its "Abuse and Misuse Deterrent Transdermal Systems" patent that protects its Aversa abuse deterrent transdermal technology.

The company said the technology is now patented in 46 countries and territories and plans to file for US Food and Drug Administration approval for Aversa Fentanyl in H1 2025.

Price: 3.94, Change: +0.02, Percent Change: +0.51